| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,207,755 | 1,242,744 | 1,203,060 | 1,373,798 | | Cost of Revenue | 2,004,144 | 388,789 | 378,485 | 3,426,086 | | | Gross Profit | (796,389) | 853,955 | 824,575 | (2,052,288) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,098,507) | 553,623 | 544,884 | (2,392,293) | | Non Recurring | (1,977) | (2,854) | 212 | 52,112 | | Others | 218,849 | 224,569 | 222,521 | 213,656 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 85,246 | 78,617 | 56,958 | 74,237 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,117 |
-
|
-
| 543 | | Earnings Before Interest And Taxes | 88,363 | 78,617 | 56,958 | 74,780 | | Interest Expense | 34,427 | 37,286 | 38,807 | 41,602 | | Income Before Tax | 53,936 | 41,331 | 18,151 | 33,178 | | Income Tax Expense | 16,144 | 18,443 | 11,313 | 22,532 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 37,792 | 22,888 | 6,838 | 10,646 | | | Non-recurring Events | | Discontinued Operations | (13,821) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,971 | 22,888 | 6,838 | 10,646 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,971 | $22,888 | $6,838 | $10,646 |
|
1.48% Nasdaq 
Income Statement
